BioAesthetics Corporation news

BioAesthetics Announces University Clinical Study for its Nipple Reconstruction Graft

BioAesthetics Corporation today announced a clinical study of its nipple reconstruction graft will be performed at Stanford Medicine beginning in 2021. The BioAesthetics® NACgraft

Dec. 3, 2020

BioAesthetics Surpasses Series A Goal Further Advancing the Nipple-Areolar Complex Graft to Clinical Use

BioAesthetics Corporation today announced that it has significantly surpassed its Series A funding goal of $2.5 million, further advancing its inaugural product — the nipple-areolar complex (NAC) graft, or NACgraf

Oct. 1, 2020

BioAesthetics Accelerates Growth with Research Breakthrough and Regional Expansion

BioAesthetics Corporation, a company transforming plastic and reconstructive surgeries through regenerative medicine, closed a financing round led by Silicon Valley-based Hemi Ventures. Investors included San Francisco’s IndieBio, t

May. 1, 2018